Invasive breast carcinoma - IARC

1937. Mukai M, Torikata C, Iri H (1990).
Alveolar soft part sarcoma: an electron
microscopic study especially of uncrystal -
lized granules using a tannic acid-containing
fixative. Ultrastruct Pathol 14: 41-50.
1938. Muller CY, O'Boyle JD, Fong KM,
Wistuba II, Biesterveld E, Ahmadian M,
Miller DS, Gazdar AF, Minna JD (1998).
Abnormalities of fragile histidine triad
genomic and complementary DNAs in cervical
cancer: association with human
papillomavirus type. J Natl Cancer Inst 90:
433-439.
1939. Mulvany NJ, Nirenberg A, Östör AG
(1996). Non-primary cervical adenocarcinomas.
Pathology 28: 293-297.
1940. Mulvany NJ, Slavin JL, Östör AG,
Fortune DW (1994). Intravenous leiomyomatosis
of the uterus: a clinicopathologic
study of 22 cases. Int J Gynecol Pathol 13:
1-9.
1941. Munkarah A, Malone JM Jr., Budev
HD, Evans TN (1994). Mucinous adenocarcinoma
arising in a neovagina. Gynecol
Oncol 52: 272-275.
1942. Munn KE, Walker RA, Varley JM
(1995). Frequent alterations of chromosome
1 in ductal carcinoma in situ of the
breast. Oncogene 10: 1653-1657.
1943. Munoz N, Franceschi S, Bosetti C,
Moreno V, Herrero R, Shah KV, Smith J,
Meijer CJ, for the IARC Multi-centre
Cervical Cancer Study Group (2001). The
role of parity and HPV in cervical cancer:
The IARC multi-centric cas-control study.
Lancet .
1944. Munoz N, Franceschi S, Bosetti C,
Moreno V, Herrero R, Smith JS, Shah KV,
Meijer CJ, Bosch FX (2002). Role of parity
and human papillomavirus in cervical cancer:
the IARC multicentric case-control
study. Lancet 359: 1093-1101.
1945. Murad TM, Contesso G, Mouriesse H
(1981). Papillary tumors of large lactiferous
ducts. Cancer 48: 122-133.
1946. Murao T, Nakai M, Hamada E (1986).
[Intravascular papillary endothelial hyperplasia
of the breast--report of a case with
scanning electron microscopic observations].
Gan No Rinsho 32: 1471-1474.
1947. Murase E, Siegelman ES, Outwater
EK, Perez-Jaffe LA, Tureck RW (1999).
Uterine leiomyomas: histopathologic features,
MR imaging findings, differential
diagnosis, and treatment. Radiographics
19: 1179-1197.
1948. Murayama Y, Yamamoto Y,
Shimojima N, Takahara T, Kikuchi K, Iida S,
Kondo Y (1999). T1 Breast Cancer
Associated with Von Recklinghausen's
Neurofibromatosis. Breast Cancer 6: 227-
230.
1949. Murphy DS, Hoare SF, Going JJ,
Mallon EE, George WD, Kaye SB, Brown R,
Black DM, Keith WN (1995).
Characterization of extensive genetic
alterations in ductal carcinoma in situ by
fluorescence in situ hybridization and
molecular analysis. J Natl Cancer Inst 87:
1694-1704.
1950. Murphy GF, Elder DE (1991). Nonmelanocytic
Tumors of the Skin. Atlas of
Tumor Pathology, 3rd series, Fascicle 1
AFIP: Washington,D.C.
1951. Musgrave MA, Aronson KJ, Narod S,
Hanna W, Miller AB, McCready DR (1998).
Breast cancer and organochlorines: a
marker for susceptibility? Surg Oncol 7: 1-
4.
1952. Mussurakis S, Carleton PJ, Turnbull
LW (1997). MR imaging of primary non-
Hodgkin's breast lymphoma. A case report.
Acta Radiol 38: 104-107.
1953. Muto MG, Lage JM, Berkowitz RS,
Goldstein DP, Bernstein MR (1991).
Gestational trophoblastic disease of the
fallopian tube. J Reprod Med 36: 57-60.
1954. Muto MG, Welch WR, Mok SC,
Bandera CA, Fishbaugh PM, Tsao SW, Lau
CC, Goodman HM, Knapp RC, Berkowitz RS
(1995). Evidence for a multifocal origin of
papillary serous carcinoma of the peritoneum.
Cancer Res 55: 490-492.
1955. Mutter GL (2000). Endometrial
intraepithelial neoplasia (EIN): will it bring
order to chaos? The Endometrial
Collaborative Group. Gynecol Oncol 7 6 :
287-290.
1956. Mutter GL (2000). Histopathology of
genetically defined endometrial precancers.
Int J Gynecol Pathol 19: 301-309.
1957. Mutter GL (2001). Pten, a protean
tumor suppressor. Am J Pathol 158: 1895-
1898.
1958. Mutter GL, Baak JP, Crum CP, Richart
RM, Ferenczy A, Faquin WC (2000).
Endometrial precancer diagnosis by
histopathology, clonal analysis, and computerized
morphometry. J Pathol 190: 462-
469.
1959. Mutter GL, Ince TA, Baak JP, Kust
GA, Zhou XP, Eng C (2001). Molecular identification
of latent precancers in histologically
normal endometrium. Cancer Res 61:
4311-4314.
1960. Myles JL, Hart WR (1985). Apoplectic
leiomyomas of the uterus. A clinicopathologic
study of five distinctive hemorrhagic
leiomyomas associated with oral contraceptive
usage. Am J Surg Pathol 9: 798-
805.
1961. Naganawa S, Endo T, Aoyama H,
Ichihara S (1996). MR lmaging of the
Primary Breast Lymphoma: A Case Report.
Breast Cancer 3: 209-213.
1962. Nagasaki K, Maass N, Manabe T,
Hanzawa H, Tsukada T, Kikuchi K,
Yamaguchi K (1999). Identification of a
novel gene, DAM1, amplified at chromosome
1p13.3-21 region in human breast
cancer cell lines. Cancer Lett 140: 219-226.
1963. Nagle RB, Bocker W, Davis JR, Heid
HW, Kaufmann M, Lucas DO, Jarasch ED
(1986). Characterization of breast carcinomas
by two monoclonal antibodies distinguishing
myoepithelial from luminal epithelial
cells. J Histochem Cytochem 3 4 :
869-881.
1964. Nakagawa S, Yoshikawa H, Kimura
M, Kawana K, Matsumoto K, Onda T, Kino
N, Yamada M, Yasugi T, Taketani Y (1999).
A possible involvement of aberrant expression
of the FHIT gene in the carcinogenesis
of squamous cell carcinoma of the uterine
cervix. Br J Cancer 79: 589-594.
1965. Nakamura Y, Nakashima T,
Nakashima H, Hashimoto T (1981). Bilateral
cystic nephroblastomas and botryoid sarcoma
involving vagina and urinary bladder
in a child with microcephaly, arhinencephaly,
and bilateral cataracts. Cancer
48: 1012-1015.
1966. Nakanishi T, Wakai K, Ishikawa H,
Nawa A, Suzuki Y, Nakamura S, Kuzuya K
(2001). A comparison of ovarian metastasis
between squamous cell carcinoma and
adenocarcinoma of the uterine cervix.
Gynecol Oncol 82: 504-509.
1967. Nakano T, Oka K, Ishikawa A, Morita
S (1997). Correlation of cervical carcinoma
c-erb B-2 oncogene with cell proliferation
parameters in patients treated with radiation
therapy for cervical carcinoma.
Cancer 79: 513-520.
1968. Nakashima N, Fukatsu T, Nagasaka
T, Sobue M, Takeuchi J (1987). The frequency
and histology of hepatic tissue in
germ cell tumors. Am J Surg Pathol 11:
682-692.
1969. Nakashima N, Murakami S, Fukatsu
T, Nagasaka T, Fukata S, Ohiwa N, Nara Y,
Sobue M, Takeuchi J (1988).
Characteristics of "embryoid body" in
human gonadal germ cell tumors. Hum
Pathol 19: 1144-1154.
1970. Nakashima N, Nagasaka T, Fukata S,
Oiwa N, Nara Y, Fukatsu T, Takeuchi J
(1990). Study of ovarian tumors treated at
Nagoya University Hospital, 1965-1988.
Gynecol Oncol 37: 103-111.
1971. Nakashima N, Young RH, Scully RE
(1984). Androgenic granulosa cell tumors
of the ovary. A clinicopathologic analysis
of 17 cases and review of the literature.
Arch Pathol Lab Med 108: 786-791.
1972. Nanbu K, Konishi I, Yamamoto S,
Koshiyama M, Mandai M, Komatsu T, Li W,
Tokushige M, Higuchi K, Mori T (1995).
Minimal deviation adenocarcinoma of
endometrioid type may arise in the isthmus:
clinicopathological and immunohistochemical
study of two cases. G y n e c o l
Oncol 58: 136-141.
1973. Naresh KN, Ahuja VK, Rao CR,
Mukherjee G, Bhargava MK (1991).
Squamous cell carcinoma arising in
endometriosis of the ovary. J Clin Pathol
44: 958-959.
1974. Narod S, Tonin P, Lynch H, Watson P,
Feunteun J, Lenoir G (1994). Histology of
BRCA1-associated ovarian tumours.
Lancet 343: 236.
1975. Narod SA (2002). Modifiers of risk of
hereditary breast and ovarian cancer. Nat
Rev Cancer 2: 113-123.
1976. Narod SA, Brunet JS, Ghadirian P,
Robson M, Heimdal K, Neuhausen SL,
Stoppa-Lyonnet D, Lerman C, Pasini B, de
los Rios P, Weber B, Lynch H (2000).
Tamoxifen and risk of contralateral breast
cancer in BRCA1 and BRCA2 mutation carriers:
a case-control study. Hereditary
Breast Cancer Clinical Study Group.
Lancet 356: 1876-1881.
1977. Narod SA, Dube MP, Klijn J, Lubinski
J, Lynch HT, Ghadirian P, Provencher D,
Heimdal K, Moller P, Robson M, Offit K,
Isaacs C, Weber B, Friedman E, Gershoni-
Baruch R, Rennert G, Pasini B, Wagner T,
Daly M, Garber JE, Neuhausen SL,
Ainsworth P, Olsson H, Evans G, Osborne
M, Couch F, Foulkes WD, Warner E, Kim-
Sing C, Olopade O, Tung N, Saal HM,
Weitzel J, Merajver S, Gauthier-Villars M,
Jernstrom H, Sun P, Brunet JS (2002). Oral
contraceptives and the risk of breast cancer
in BRCA1 and BRCA2 mutations carriers.
J Natl Cancer Inst 94: 1773-1779.
1978. Narod SA, Goldgar D, Cannon-
Albright L, Weber B, Moslehi R, Ives E,
Lenoir G, Lynch H (1995). Risk modifiers in
carriers of BRCA1 mutations. Int J Cancer
64: 394-398.
1979. Narod SA, Risch H, Moslehi R, Dorum
A, Neuhausen S, Olsson H, Provencher D,
Radice P, Evans G, Bishop S, Brunet JS,
Ponder BA (1998). Oral contraceptives and
the risk of hereditary ovarian cancer.
Hereditary Ovarian Cancer Clinical Study
Group. N Engl J Med 339: 424-428.
1980. Narod SA, Sun P, Ghadirian P, Lynch
H, Isaacs C, Garber J, Weber B, Karlan B,
Fishman D, Rosen B, Tung N, Neuhausen
SL (2001). Tubal ligation and risk of ovarian
cancer in carriers of BRCA1 or BRCA2
mutations: a case-control study. Lancet
357: 1467-1470.
1981. Nascimento AG, Karas M, Rosen PP,
Caron AG (1979). Leiomyoma of the nipple.
Am J Surg Pathol 3: 151-154.
1982. Nassar H, Wallis T, Andea A, Dey J,
Adsay V, Visscher D (2001).
Clinicopathologic analysis of invasive
micropapillary differentiation in breast carcinoma.
Mod Pathol 14: 836-841.
1983. Nasu M, Inoue J, Matsui M, Minoura
S, Matsubara O (2000). Ovarian
leiomyosarcoma: an autopsy case report.
Pathol Int 50: 162-165.
1984. National Co-ordinating Group for
Breast Screening Pathology (1995).
Pathology Reporting. In: Breast Screening
Pathology, Breast Screening Pathology,
2nd ed. ed. NHSBSP Publications.
1 9 8 5 . Navani SS, Alvarado-Cabrero I,
Young RH, Scully RE (1996). Endometrioid
carcinoma of the fallopian tube: a clinicopathologic
analysis of 26 cases. Gynecol
Oncol 63: 371-378.
1986. Naves AE, Monti JA, Chichoni E
(1980). Basal cell-like carcinoma in the
upper third of the vagina. Am J Obstet
Gynecol 137: 136-137.
1987. Nayar R, Siriaunkgul S, Robbins KM,
McGowan L, Ginzan S, Silverberg SG
(1996). Microinvasion in low malignant
potential tumors of the ovary. Hum Pathol
27: 521-527.
1988. Nayar R, Zhuang Z, Merino MJ,
Silverberg SG (1997). Loss of heterozygosity
on chromosome 11q13 in lobular lesions
of the breast using tissue microdissection
and polymerase chain reaction. H u m
Pathol 28: 277-282.
1989. Nelen MR, Kremer H, Konings IB,
Schoute F, van Essen AJ, Koch R, Woods
CG, Fryns JP, Hamel B, Hoefsloot LH,
Peeters EA, Padberg GW (1999). Novel
PTEN mutations in patients with Cowden
disease: absence of clear genotype-phenotype
correlations. Eur J Hum Genet 7:
267-273.
1990. Nelen MR, Padberg GW, Peeters EA,
Lin AY, van den Helm B, Frants RR, Coulon
V, Goldstein AM, van Reen MM, Easton DF,
Eeles RA, Hodgsen S, Mulvihill JJ, Murday
VA, Tucker MA, Mariman EC, Starink TM,
Ponder BA, Ropers HH, Kremer H, Longy
M, Eng C (1996). Localization of the gene
for Cowden disease to chromosome
10q22-23. Nat Genet 13: 114-116.
1991. Nelen MR, van Staveren WC, Peeters
EA, Hassel MB, Gorlin RJ, Hamm H,
Lindboe CF, Fryns JP, Sijmons RH, Woods
DG, Mariman EC, Padberg GW, Kremer H
(1997). Germline mutations in the
PTEN/MMAC1 gene in patients with
Cowden disease. Hum Mol Genet 6: 1383-
1387.
1992. Nelson CL, Sellers TA, Rich SS, Potter
JD, McGovern PG, Kushi LH (1993). Familial
clustering of colon, breast, uterine, and
ovarian cancers as assessed by family history.
Genet Epidemiol 10: 235-244.
1993. Nemoto T, Castillo N, Tsukada Y, Koul
A, Eckhert KH Jr., Bauer RL (1998). Lobular
carcinoma in situ with microinvasion. J
Surg Oncol 67: 41-46.
1994. Nesland JM, Holm R, Johannessen
JV (1985). Ultrastructural and immunohistochemical
features of lobular carcinoma
of the breast. J Pathol 145: 39-52.
References 403